Cargando…
Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
An accurate diagnosis of Alzheimer’s disease (AD) currently stands as one of the most difficult and challenging in all of clinical neurology. AD is typically diagnosed using an integrated knowledge and assessment of multiple biomarkers and interrelated factors. These include the patient’s age, gende...
Autores principales: | Lukiw, Walter J., Vergallo, Andrea, Lista, Simone, Hampel, Harald, Zhao, Yuhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565758/ https://www.ncbi.nlm.nih.gov/pubmed/32967128 http://dx.doi.org/10.3390/jpm10030138 |
Ejemplares similares
-
microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020) -
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019) -
Recent Advances in Our Molecular and Mechanistic Understanding of Misfolded Cellular Proteins in Alzheimer’s Disease (AD) and Prion Disease (PrD)
por: Lukiw, Walter J.
Publicado: (2022) -
Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus
por: Zhao, Yuhai, et al.
Publicado: (2017) -
MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
por: Vergallo, Andrea, et al.
Publicado: (2021)